-
1
-
-
0031963294
-
Cancer statistics, 1998
-
10.3322/canjclin.48.1.6 9449931
-
Cancer statistics, 1998. SH Landis T Murray S Bolden PA Wingo, CA Cancer J Clin 1998 48 1 6 29 10.3322/canjclin.48.1.6 9449931
-
(1998)
CA Cancer J Clin
, vol.48
, Issue.1
, pp. 6-29
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
0032487923
-
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
-
DOI 10.1056/NEJM199811053391901
-
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. SL Soignet P Maslak ZG Wang S Jhanwar E Calleja LJ Dardashti D Corso A DeBlasio J Gabrilove DA Scheinberg PP Pandolfi RP Warrell Jr, N Engl J Med 1998 339 19 1341 1348 10.1056/NEJM199811053391901 9801394 (Pubitemid 28509343)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.19
, pp. 1341-1348
-
-
Soignet, S.L.1
Maslak, P.2
Wang, Z.-G.3
Jhanwar, S.4
Calleja, E.5
Dardashti, L.J.6
Corso, D.7
DeBlasio, A.8
Gabrilove, J.9
Scheinberg, D.A.10
Pandolfi, P.P.11
Warrell Jr., R.P.12
-
3
-
-
0000531696
-
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells
-
10.1093/jnci/90.2.124 9450572
-
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. W Shao M Fanelli FF Ferrara R Riccioni A Rosenauer K Davison WW Lamph S Waxman PG Pelicci F Lo Coco G Avvisati U Testa C Peschle C Gambacorti-Passerini C Nervi WH Miller Jr, J Natl Cancer Inst 1998 90 2 124 133 10.1093/jnci/90.2.124 9450572
-
(1998)
J Natl Cancer Inst
, vol.90
, Issue.2
, pp. 124-133
-
-
Shao, W.1
Fanelli, M.2
Ferrara, F.F.3
Riccioni, R.4
Rosenauer, A.5
Davison, K.6
Lamph, W.W.7
Waxman, S.8
Pelicci, P.G.9
Lo Coco, F.10
Avvisati, G.11
Testa, U.12
Peschle, C.13
Gambacorti-Passerini, C.14
Nervi, C.15
Miller Jr, W.H.16
-
4
-
-
0032554052
-
Arsenic and apoptosis in the treatment of acute promyelocytic leukemia
-
10.1093/jnci/90.2.86 9450562
-
Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. AT Look, J Natl Cancer Inst 1998 90 2 86 88 10.1093/jnci/90.2.86 9450562
-
(1998)
J Natl Cancer Inst
, vol.90
, Issue.2
, pp. 86-88
-
-
Look, A.T.1
-
5
-
-
0030610686
-
3 exerts dose-dependent dual effects on APL cells
-
Use of arsenic trioxide (As 2 O 3 ) in the treatment of acute promyelocytic leukemia (APL): I. As 2 O 3 exerts dose-dependent dual effects on APL cells. GQ Chen XG Shi W Tang SM Xiong J Zhu X Cai ZG Han JH Ni GY Shi PM Jia MM Liu KL He C Niu J Ma P Zhang TD Zhang P Paul T Naoe K Kitamura W Miller S Waxman ZY Wang H de The SJ Chen Z Chen, Blood 1997 89 9 3345 3353 9129041 (Pubitemid 27229821)
-
(1997)
Blood
, vol.89
, Issue.9
, pp. 3345-3353
-
-
Chen, G.-Q.1
Shi, X.-G.2
Tang, W.3
Xiong, S.-M.4
Zhu, J.5
Cai, X.6
Man, Z.-G.7
Ni, J.-H.8
Shi, G.-Y.9
Jia, P.-M.10
Liu, M.-M.11
He, K.-L.12
Niu, C.13
Ma, J.14
Zhang, P.15
Zhang, T.-D.16
Paul, P.17
Naoe, T.18
Kitamura, K.19
Miller, W.20
Waxman, S.21
Wang, Z.-Y.22
De The, H.23
Chen, S.-J.24
Chen, Z.25
more..
-
6
-
-
17144447877
-
2/M arrest, and apoptosis
-
DOI 10.1006/excr.1998.4066
-
The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. ZM Shao M Nguyen ML Alpaugh JT O'Connell SH Barsky, Exp Cell Res 1998 241 2 394 403 10.1006/excr.1998.4066 9637781 (Pubitemid 28366565)
-
(1998)
Experimental Cell Research
, vol.241
, Issue.2
, pp. 394-403
-
-
Shao, Z.-M.1
Nguyen, M.2
Alpaugh, M.L.3
O'Connell, J.T.4
Barsky, S.H.5
-
7
-
-
60549100517
-
TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma
-
19077262 10.1186/1756-9966-27-82
-
TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. A Daigeler C Brenzel D Bulut A Geisler C Hilgert M Lehnhardt HU Steinau A Flier L Steinstraesser L Klein-Hitpass U Mittelkötter W Uhl AM Chromik, J Exp Clin Cancer Res 2008 27 82 19077262 10.1186/1756-9966-27-82
-
(2008)
J Exp Clin Cancer Res
, vol.27
, pp. 82
-
-
Daigeler, A.1
Brenzel, C.2
Bulut, D.3
Geisler, A.4
Hilgert, C.5
Lehnhardt, M.6
Steinau, H.U.7
Flier, A.8
Steinstraesser, L.9
Klein-Hitpass, L.10
Mittelkötter, U.11
Uhl, W.12
Chromik, A.M.13
-
8
-
-
0033033754
-
Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells
-
10385689
-
Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells. JR Gurr DT Bau F Liu S Lynn KY Jan, Mol Pharmacol 1999 56 1 102 109 10385689
-
(1999)
Mol Pharmacol
, vol.56
, Issue.1
, pp. 102-109
-
-
Gurr, J.R.1
Bau, D.T.2
Liu, F.3
Lynn, S.4
Jan, K.Y.5
-
9
-
-
0027299417
-
Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts
-
DOI 10.1016/0165-7992(93)90010-S
-
Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. JT Dong XM Luo, Mutat Res 1993 302 2 97 102 10.1016/0165-7992(93)90010-S 7684511 (Pubitemid 23151436)
-
(1993)
Mutation Research - Mutation Research Letters
, vol.302
, Issue.2
, pp. 97-102
-
-
Dong, J.-T.1
Luo, X.-M.2
-
10
-
-
0036765344
-
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines
-
DOI 10.1124/mol.62.3.529
-
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. YH Ling JD Jiang JF Holland R Perez-Soler, Mol Pharmacol 2002 62 3 529 538 10.1124/mol.62.3.529 12181429 (Pubitemid 36329371)
-
(2002)
Molecular Pharmacology
, vol.62
, Issue.3
, pp. 529-538
-
-
Ling, Y.-H.1
Jiang, J.-D.2
Holland, J.F.3
Perez-Soler, R.4
-
11
-
-
0010740572
-
In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As 2 O 3) in the treatment of acute promyelocytic leukemia: As 2 O 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
-
in vitro studies on cellular and molecular mechanisms of arsenic trioxide (As 2 O 3 ) in the treatment of acute promyelocytic leukemia: As 2 O 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. GQ Chen J Zhu XG Shi JH Ni HJ Zhong GY Si XL Jin W Tang XS Li SM Xong ZX Shen GL Sun J Ma P Zhang TD Zhang C Gazin T Naoe SJ Chen ZY Wang Z Chen, Blood 1996 88 3 I1052 1061
-
(1996)
Blood
, vol.88
, Issue.3
, pp. 1052-1061
-
-
Chen, G.Q.1
Zhu, J.2
Shi, X.G.3
Ni, J.H.4
Zhong, H.J.5
Si, G.Y.6
Jin, X.L.7
Tang, W.8
Li, X.S.9
Xong, S.M.10
Shen, Z.X.11
Sun, G.L.12
Ma, J.13
Zhang, P.14
Zhang, T.D.15
Gazin, C.16
Naoe, T.17
Chen, S.J.18
Wang, Z.Y.19
Chen, Z.20
more..
-
12
-
-
0033526398
-
Arsenic trioxide, a novel mitochondriotoxic anticancer agent?
-
10.1093/jnci/91.9.743 10328097
-
Arsenic trioxide, a novel mitochondriotoxic anticancer agent? G Kroemer H de The, J Natl Cancer Inst 1999 91 9 743 745 10.1093/jnci/91.9.743 10328097
-
(1999)
J Natl Cancer Inst
, vol.91
, Issue.9
, pp. 743-745
-
-
Kroemer, G.1
De The, H.2
-
13
-
-
27144556401
-
Clusterin as a therapeutic target for radiation sensitization in a lung cancer model
-
DOI 10.1016/j.ijrobp.2005.07.956, PII S0360301605021437
-
Clusterin as a therapeutic target for radiation sensitization in a lung cancer model. C Cao ET Shinohara H Li KJ Niermann KW Kim KR Sekhar M Gleave M Freeman B Lu, Int J Radiat Oncol Biol Phys 2005 63 4 1228 1236 16253777 (Pubitemid 41505304)
-
(2005)
International Journal of Radiation Oncology Biology Physics
, vol.63
, Issue.4
, pp. 1228-1236
-
-
Cao, C.1
Shinohara, E.T.2
Li, H.3
Niermann, K.J.4
Kwang, W.K.5
Sekhar, K.R.6
Gleave, M.7
Freeman, M.8
Lu, B.9
-
14
-
-
4344616635
-
2-M phase arrest and cell death in PC-3 prostate cancer cells
-
DOI 10.1158/0008-5472.CAN-04-0920
-
Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. M Scaltriti A Santamaria R Paciucci S Bettuzzi, Cancer research 2004 64 17 6174 6182 10.1158/0008-5472.CAN-04-0920 15342402 (Pubitemid 39129419)
-
(2004)
Cancer Research
, vol.64
, Issue.17
, pp. 6174-6182
-
-
Scaltriti, M.1
Santamaria, A.2
Paciucci, R.3
Bettuzzi, S.4
-
15
-
-
38949153810
-
A phase I study of OGX-011, a 2′-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer
-
DOI 10.1158/1078-0432.CCR-07-1310
-
A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer. KN Chi LL Siu H Hirte SJ Hotte J Knox C Kollmansberger M Gleave E Guns J Powers W Walsh D Tu E Eisenhauer, Clin Cancer Res 2008 14 3 833 839 10.1158/1078-0432. CCR-07-1310 18245546 (Pubitemid 351231167)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.3
, pp. 833-839
-
-
Chi, K.N.1
Siu, L.L.2
Hirte, H.3
Hotte, S.J.4
Knox, J.5
Kollmansberger, C.6
Gleave, M.7
Guns, E.8
Powers, J.9
Walsh, W.10
Tu, D.11
Eisenhauer, E.12
-
16
-
-
3242666392
-
Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells
-
14617789
-
Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. J McCafferty-Grad NJ Bahlis N Krett TM Aguilar I Reis KP Lee LH Boise, Molecular cancer therapeutics 2003 2 11 1155 1164 14617789
-
(2003)
Molecular Cancer Therapeutics
, vol.2
, Issue.11
, pp. 1155-1164
-
-
McCafferty-Grad, J.1
Bahlis, N.J.2
Krett, N.3
Aguilar, T.M.4
Reis, I.5
Lee, K.P.6
Boise, L.H.7
-
17
-
-
0033974883
-
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
-
10.1038/sj.leu.2401650 10673743
-
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. X Cai YL Shen Q Zhu PM Jia Y Yu L Zhou Y Huang JW Zhang SM Xiong SJ Chen ZY Wang Z Chen GQ Chen, Leukemia 2000 14 2 262 270 10.1038/sj.leu.2401650 10673743
-
(2000)
Leukemia
, vol.14
, Issue.2
, pp. 262-270
-
-
Cai, X.1
Shen, Y.L.2
Zhu, Q.3
Jia, P.M.4
Yu, Y.5
Zhou, L.6
Huang, Y.7
Zhang, J.W.8
Xiong, S.M.9
Chen, S.J.10
Wang, Z.Y.11
Chen, Z.12
Chen, G.Q.13
-
18
-
-
2442583335
-
Arsenic Trioxide-Induced Death of Neuroblastoma Cells Involves Activation of Bax and Does Not Require p53
-
DOI 10.1158/1078-0432.CCR-03-0309
-
Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. J Karlsson I Ora I Porn-Ares S Pahlman, Clin Cancer Res 2004 10 9 3179 3188 10.1158/1078-0432.CCR-03-0309 15131059 (Pubitemid 38619699)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.9
, pp. 3179-3188
-
-
Karlsson, J.1
Ora, I.2
Porn-Ares, I.3
Pahlman, S.4
|